International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

When to Compound Medications for Veterinary Patients

Author(s): Forsythe Lauren Eichstadt

Issue: Jan/Feb 2017 - Volume 21, Number 1
View All Articles in Issue

Page(s): 19-21

When to Compound Medications for Veterinary Patients Page 1

When to Compound Medications for Veterinary Patients Page 2

When to Compound Medications for Veterinary Patients Page 3

Download in electronic PDF format for $75

Abstract: This article serves as a brief discussion about some of the restrictions applicable to compounding medications for veterinary patients based on U. S. Food and Drug Administration compliance policy guidelines and provides a brief summary of when it is appropriate to compound medications for veterinary patients.

Related Keywords: Lauren Eichstadt Forsythe, PharmD, FSVHP, U.S. Food and Drug Administration, FDA, regulation, regulatory policy, compliance policy guidelines, CPG, veterinary practice, Animal Medicinal Drug Use Clarification Act, AMDUCA, extra-label drug use, food animals, bulk chemicals, Food Animal Residue Avoidance Databank, FARAD

Related Categories: LEGAL, VETERINARY, INFORMATION RESOURCES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
When to Compound Medications for Veterinary Patients Forsythe Lauren Eichstadt	Jan/Feb 2017 Pg. 19-21
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Brunner Scott	Jan/Feb 2023 Pg. 22-23
Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2 Davidson Gigi S	May/Jun 2001 Pg. 214-215
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Allen Loyd V Jr, Ashworth Lisa D	Jan/Feb 2005 Pg. 44-46
Drugs Banned for Use in Food Animals: An Explanation Davidson Gigi S	Mar/Apr 2001 Pg. 101-103
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug	Mar/Apr 2017 Pg. 95-102
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Brunner Scott	Jul/Aug 2020 Pg. 296-297
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Chan Debora Schotik	Mar/Apr 2001 Pg. 97-100
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)	Nov/Dec 2016 Pg. 457-458
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Allen Loyd V Jr	Jul/Aug 2007 Pg. 350-351
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Miller David G	May/Jun 2014 Pg. 208
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Martin Matt	Sep/Oct 2018 Pg. 401-404
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A	Jan/Feb 2019 Pg. 32-33
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1 Davidson Gigi S	Mar/Apr 2001 Pg. 95-96
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration Kupiec Tom, Kemp Jesse	Jul/Aug 2007 Pg. 326-327
Return to Top